在恶性间皮瘤中KLHL14抗瘤作用的表征

Angelo Canciello1,2, Reyes Benot Domínguez1, Barbara Barboni2

  • 1Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.

Heliyon
|March 21, 2024
PubMed
概括

凯尔奇样14 (KLHL14) 蛋白质通过抑制表皮细胞-介质细胞转变来预防恶性间皮瘤的进展. 转化生长因子β (TGF-β) 调节KLHL14,提供潜在的治疗点.